NCT07572396: Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities
- State
- Under way
- Phase
- Phase 2
- People
- 45 planned
- Started
- 30 Apr 2026
- Primary completion
- 27 Dec 2026
- Arms
- Dysplasix™ Intravaginal Suppositories
- Results
- None posted
- 7 May 2026: Trial registered